Product
Dilanubicel
Aliases
Allogeneic UCB-derived Hematopoietic Stem and Progenitor Cells NLA101, Allogeneic Umbilical Cord Blood-derived HSPCs NLA101, NLA101
2 clinical trials
12 indications
Indication
Acute Biphenotypic LeukemiaIndication
Acute Lymphoblastic LeukemiaIndication
Chronic Myelogenous LeukemiaIndication
BCR-ABL1-positiveIndication
Hematopoietic and Lymphoid Cell NeoplasmIndication
Myelodysplastic SyndromeIndication
Acute Erythroid LeukemiaIndication
Acute Megakaryoblastic LeukemiaIndication
Acute Myeloid LeukemiaIndication
HIV InfectionIndication
Non-Hodgkin lymphomaIndication
Refractory AnemiaClinical trial
Pilot Study: Infusion of Off-the-Shelf Ex Vivo Expanded Cryopreserved Progenitor Cells (Dilanubicel) in the Setting of Single Cord Blood Transplantation for Patients With Hematologic MalignanciesStatus: Recruiting, Estimated PCD: 2024-10-08
Clinical trial
Infusion of Off-the-Shelf Ex Vivo Expanded Cryopreserved Progenitor Cells to Facilitate the Engraftment of a Single CCR5Δ32 Homozygous or Heterozygous Cord Blood Unit in Patients With HIV and Hematological MalignanciesStatus: Terminated, Estimated PCD: 2022-11-11